Company Information

  

Address: 664 CRUISER LANE  
City: BELGRADE 
State: MT 
Zip Code: 59714 
Telephone: 406-388-0480 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

Xtant Medical Holdings, Inc. develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. Xtant believes the following competitive strengths will be key drivers of future growth of Xtant: Portfolio of Proprietary Technologies: Xtant has developed a comprehensive portfolio of products that address a broad array of spinal pathologies, anatomies and surgical approaches in the complex spine and minimally invasive surgery ("MIS") markets.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2018-25.45NAN/E
03/2018-31.59NAN/E
12/2017-417.14NAN/E
09/2017-234.73NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.61Total Liab/Total Assets1.56
Net Inc/Total Assets-0.50Total Liab/Inv Cap2.07
Net Inc/Inv Cap-0.66Total Liab/Comm Equity1.91
Pretax Inc/Net Sales-0.63Interest Coverage Ratio-2.56
Net Inc/Net Sales-0.63Curr Debt/Equity-0.01
Cash Flow/Net Sales-0.01LTD/Equity-2.36
SG&A/NetSales0.70Total Debt/Equity-2.37
Asset Utilization   Liquidity  
Net Receivables Turnover5.21Quick Ratio0.67
Inventory Turnover1.34Current Ratio1.53
Inventory Day Sales0.00Net Rec/Curr Assets0.32
Net Sales/Work Cap6.04Inv/Curr Assets0.56
Net Sales/PP&E8.17  

Income Statement (Millions)

  6/30/2018 3/31/2018 12/31/2017 9/30/2017
Total Revenues(Net Sales) 18.74 17.93 19.33 19.79
Cost of Goods Sold 6.27 5.70 9.04 8.42
Selling & Admin Exps 12.04 11.74 13.11 13.00
Operating Income -2.26 -1.66 -27.06 -1.86
Interest Exp 2.82 3.55 4.17 3.81
Pretax Income -5.00 -5.25 -28.42 -8.51
Other Income 0.08 -0.05 2.81 -2.84
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -5.00 -5.25 -28.42 -8.51

Balance Sheet (Millions)

Assets 6/30/2018 3/31/2018 12/31/2017 9/30/2017
Cash & Short Term Investments 6.05 6.17 2.86 2.07
Receivables - Total 10.40 10.34 12.71 13.91
Inventories - Total 22.45 22.51 22.23 24.04
Total Current Assets 39.70 40.13 39.50 40.68
Net Property, Plant & Equipment 8.93 9.47 10.11 12.17
Total Assets 102.79 104.78 105.70 128.46
Liabilities        
Accounts Payable 11.84 11.44 25.32 21.12
Debt in Current Liabilities 0.56 0.55 0.50 66.13
Total Current Liabilities 12.40 12.00 25.82 87.25
Long-Term Debt 79.78 77.18 138.59 71.44
Total Liabilities 92.18 89.17 164.40 158.69
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -155.52 -150.20 -144.95 -116.53
Treasury Stock NA NA NA NA
Total Stockholders' Equity 10.61 15.61 -58.70 -30.23
Total Liabilities and Stockholders' Equity 102.79 104.78 105.70 128.46

Cash Flow Summary (Millions)

Categories 6/30/2018 3/31/2018 12/31/2017 9/30/2017
Net Cash Provided by Operating Activities 0.11 0.24 0.65 -0.43
Net Cash Provided by Investing Activities -0.16 -0.13 -0.15 -0.39
Net Cash Provided by Financing Activities -0.08 3.21 0.29 1.22

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201333.07-12.69--
12/201435.33-10.51--
12/201559.35-2.17--
12/201690.00-19.49--
12/201782.61-52.41-417.14
Growth Rates25.72----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/181811,14784.80




Report Date : 9/24/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.